Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04339738
Title Testing the Addition of Nivolumab to Chemotherapy in Treatment of Soft Tissue Sarcoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

angiosarcoma

skin angiosarcoma

Therapies

Cabozantinib + Nivolumab

Nivolumab + Paclitaxel

Paclitaxel

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.